2017 Astellas Transparency Disclosure Report
Astellas is a member company of the European Federation of Pharmaceutical Industries and Associations (“EFPIA”) and adheres to the EFPIA Disclosure Code 2014 (the “EFPIA Disclosure Code”).
The EFPIA Disclosure Code requires all member companies to document and disclose certain Transfers of Value they make, directly or indirectly, to or for the benefit of, Healthcare Professionals (“HCPs”) or Healthcare Organisations (“HCOs”) (“Disclosures”).
The EFPIA Disclosure Code is implemented in Luxembourg by Association Pharmaceutique Luxembourgeoise (APL). Astellas discloses all Transfers of Value to HCPs and HCOs in accordance with its commitment to the EFPIA Disclosure Code and any applicable Luxembourg national code.